Valeo Pharma (VPHIF)
OTHER OTC:VPHIF
Holding VPHIF?
Track your performance easily

Valeo Pharma (VPHIF) Financial Statements

14 Followers

Valeo Pharma Financial Overview

Valeo Pharma's market cap is currently ―. The company's EPS TTM is $-0.241; its P/E ratio is -0.31; Valeo Pharma is scheduled to report earnings on September 11, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Jan 24Oct 23Jul 23Apr 23Jan 23
Income Statement-
Total RevenueC$ 13.54MC$ 13.11MC$ 14.08MC$ 13.56MC$ 13.16M
Gross ProfitC$ 2.23MC$ 750.00KC$ 4.21MC$ 4.39MC$ 3.73M
EBITC$ -3.06MC$ -9.08MC$ -2.38MC$ -3.14MC$ -2.99M
EBITDAC$ -2.41MC$ -8.32MC$ -1.75MC$ -2.51MC$ -2.37M
Net Income Common StockholdersC$ -6.87MC$ -9.24MC$ -5.84MC$ -6.48MC$ -6.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 9.59MC$ 7.50MC$ 9.78MC$ 10.12MC$ 10.95M
Total AssetsC$ 40.35MC$ 41.21MC$ 45.54MC$ 48.36MC$ 47.79M
Total DebtC$ 43.47MC$ 65.76MC$ 62.79MC$ 62.81MC$ 61.87M
Net DebtC$ 33.89MC$ 58.26MC$ 53.02MC$ 52.69MC$ 50.91M
Total LiabilitiesC$ 87.37MC$ 81.54MC$ 80.58MC$ 77.53MC$ 71.36M
Stockholders EquityC$ -47.01MC$ -40.34MC$ -35.05MC$ -29.16MC$ -23.57M
Cash Flow-
Free Cash FlowC$ 1.86M-C$ -1.37MC$ -911.00KC$ -11.27M
Operating Cash FlowC$ 1.63MC$ -2.67MC$ -1.26MC$ -674.00KC$ -11.09M
Investing Cash FlowC$ 225.00KC$ -5.03MC$ -111.00KC$ -237.00KC$ -176.00K
Financing Cash FlowC$ 460.00KC$ 5.05MC$ 1.24MC$ -57.00KC$ -50.00K
Currency in CAD

Valeo Pharma Earnings and Revenue History

Valeo Pharma Debt to Assets

Valeo Pharma Cash Flow

Valeo Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis